Invera Wealth Advisors LLC Has $1.59 Million Stake in STERIS plc (NYSE:STE)

Invera Wealth Advisors LLC lifted its position in shares of STERIS plc (NYSE:STE) by 97.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,061 shares of the medical equipment provider’s stock after acquiring an additional 3,484 shares during the quarter. Invera Wealth Advisors LLC’s holdings in STERIS were worth $1,587,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Fifth Third Bancorp grew its position in shares of STERIS by 9.7% in the 3rd quarter. Fifth Third Bancorp now owns 3,041 shares of the medical equipment provider’s stock valued at $667,000 after buying an additional 268 shares during the last quarter. Fenimore Asset Management Inc. lifted its stake in shares of STERIS by 13.1% in the 4th quarter. Fenimore Asset Management Inc. now owns 210,747 shares of the medical equipment provider’s stock valued at $46,333,000 after purchasing an additional 24,377 shares during the period. Cullen Investment Group LTD. acquired a new position in shares of STERIS in the 4th quarter valued at about $1,351,000. Cerity Partners LLC lifted its stake in shares of STERIS by 5,199.4% in the 4th quarter. Cerity Partners LLC now owns 65,925 shares of the medical equipment provider’s stock valued at $14,494,000 after purchasing an additional 64,681 shares during the period. Finally, Financiere des Professionnels Fonds d investissement inc. lifted its stake in shares of STERIS by 12.9% in the 4th quarter. Financiere des Professionnels Fonds d investissement inc. now owns 45,095 shares of the medical equipment provider’s stock valued at $9,914,000 after purchasing an additional 5,168 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

STE has been the topic of a number of research reports. Stephens reaffirmed an “overweight” rating and set a $250.00 price target on shares of STERIS in a research note on Friday, February 9th. JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 8th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Friday, April 12th. KeyCorp initiated coverage on STERIS in a research note on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price objective for the company. Finally, TheStreet raised STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $239.60.

STERIS Stock Performance

Shares of STE stock traded up $1.54 during trading on Monday, hitting $205.45. The company’s stock had a trading volume of 376,503 shares, compared to its average volume of 460,642. The company has a market cap of $20.30 billion, a PE ratio of 35.98 and a beta of 0.79. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.50. The business has a fifty day moving average of $220.66 and a 200-day moving average of $216.57. STERIS plc has a 52 week low of $185.22 and a 52 week high of $254.00.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.05. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.35 billion. STERIS had a return on equity of 13.67% and a net margin of 10.48%. STERIS’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.02 earnings per share. As a group, research analysts anticipate that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend was Thursday, February 22nd. STERIS’s dividend payout ratio (DPR) is 36.43%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.